Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326).

Mace L. Rothenberg; P.Y. Liu; Sharon Wilczynski; Edward V. Hannigan; Sheldon A. Weiner; Geoffrey R. Weiss; Verda J. Hunter; Julia A. Chapman; Amy Tiersten; Peter C. Kohler; David S. Alberts

doi:10.1006/GYNO.2001.6274

Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326).

Mace L. Rothenberg
, P.Y. Liu
, Sharon Wilczynski
, Edward V. Hannigan
, Sheldon A. Weiner
, Geoffrey R. Weiss
, Verda J. Hunter
, Julia A. Chapman
, Amy Tiersten
, Peter C. Kohler
, David S. Alberts

Vanderbilt University Medical Center
Southwest Oncology Group Statistical Center, Seattle, Washington, 98109
City of Hope National Medical Center
University of Texas Medical Branch
Beaumont Hospital
University of Texas Health Science Center at San Antonio
Kansas City Community Clinical Oncology Program, Kansas City, Missouri, 64131
University of Kansas
NewYork–Presbyterian Hospital
Grand Rapids Community Clinical Oncology Program, Grand Rapids, Michigan, 49503
University of Arizona

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Gynecologic Oncology
Volume	82
Issue number	2
DOIs	https://doi.org/10.1006/GYNO.2001.6274
State	Published - Aug 1 2001
Externally published	Yes

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1006/GYNO.2001.6274License: Unspecified

Cite this

Rothenberg, M. L., Liu, P. Y., Wilczynski, S., Hannigan, E. V., Weiner, S. A., Weiss, G. R., Hunter, V. J., Chapman, J. A., Tiersten, A., Kohler, P. C., & Alberts, D. S. (2001). Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326). Gynecologic Oncology, 82(2). https://doi.org/10.1006/GYNO.2001.6274

Rothenberg, ML, Liu, PY, Wilczynski, S, Hannigan, EV, Weiner, SA, Weiss, GR, Hunter, VJ, Chapman, JA, Tiersten, A, Kohler, PC & Alberts, DS 2001, 'Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326).', Gynecologic Oncology, vol. 82, no. 2. https://doi.org/10.1006/GYNO.2001.6274

@article{2db7e782f6d74782b983fb00729e789d,

title = "Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326).",

author = "Rothenberg, \{Mace L.\} and P.Y. Liu and Sharon Wilczynski and Hannigan, \{Edward V.\} and Weiner, \{Sheldon A.\} and Weiss, \{Geoffrey R.\} and Hunter, \{Verda J.\} and Chapman, \{Julia A.\} and Amy Tiersten and Kohler, \{Peter C.\} and Alberts, \{David S.\}",

note = "Objective. The aim of this study was to evaluate the 2-year survival rate in a group of women in complete clinical remission (cCR) from Stage III ovarian cancer following front-line therapy who were then treated with a 6-month course of altretamine.Methods.",

year = "2001",

month = aug,

day = "1",

doi = "10.1006/GYNO.2001.6274",

language = "American English",

volume = "82",

journal = "Gynecologic Oncology",

issn = "1095-6859",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326).

AU - Rothenberg, Mace L.

AU - Liu, P.Y.

AU - Wilczynski, Sharon

AU - Hannigan, Edward V.

AU - Weiner, Sheldon A.

AU - Weiss, Geoffrey R.

AU - Hunter, Verda J.

AU - Chapman, Julia A.

AU - Tiersten, Amy

AU - Kohler, Peter C.

AU - Alberts, David S.

N1 - Objective. The aim of this study was to evaluate the 2-year survival rate in a group of women in complete clinical remission (cCR) from Stage III ovarian cancer following front-line therapy who were then treated with a 6-month course of altretamine.Methods.

PY - 2001/8/1

Y1 - 2001/8/1

UR - https://www.gynecologiconcology-online.net/article/S0090-8258(01)96274-2/pdf

U2 - 10.1006/GYNO.2001.6274

DO - 10.1006/GYNO.2001.6274

M3 - Article

SN - 1095-6859

VL - 82

JO - Gynecologic Oncology

JF - Gynecologic Oncology

IS - 2

ER -

Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326).

Disciplines

Access to Document

Other files and links

Cite this